Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix response and CMV status in older adults
NCT00442975Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- Mar 2007
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Fluarix in influenza, sponsored by UK Health Security Agency. Primary endpoint: Hemagglutination Inhibition. Started Mar 2007; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00442975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442975.